We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Ares Capital
ARCC
$13.9B
| $223K | ﹤0.01% |
+12,224
| New | +$231K |
|
|
ATXS
1577
DELISTED
Astria Therapeutics
ATXS
| $223K | ﹤0.01% |
+16,794
| New | +$227K |
|
|
VRNT
1578
DELISTED
Verint Systems
VRNT
| $223K | ﹤0.01% |
+5,991
| New | +$223K |
|
1579
Recursion Pharmaceuticals
RXRX
$1.76B
| $223K | ﹤0.01% |
+33,400
| New | +$265K |
|
1580
CALL
Automatic Data Processing
ADP
$106B
| $223K | ﹤0.01% |
1,000
-13,800
| -93% | -$3.11M |
|
1581
Howard Hughes
HHH
$3.93B
| $222K | ﹤0.01% |
+2,913
| New | +$227K |
|
1582
Hertz
HTZ
$483M
| $222K | ﹤0.01% |
13,618
-7,224
| -35% | -$126K |
|
1583
Brighthouse Financial
BHF
$3.59B
| $222K | ﹤0.01% |
+5,027
| New | +$264K |
|
1584
DigitalOcean
DOCN
$14.8B
| $221K | ﹤0.01% |
5,648
-14,691
| -72% | -$462K |
|
1585
East-West Bancorp
EWBC
$18.4B
| $221K | ﹤0.01% |
+3,978
| New | +$275K |
|
|
AMYT
1586
PUT
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $220K | ﹤0.01% |
+15,100
| New | +$213K |
|
1587
CALL
Lowe's Companies
LOW
$122B
| $220K | ﹤0.01% |
1,100
| – | – |
|
|
KNSW
1588
DELISTED
KnightSwan Acquisition Corporation
KNSW
| $219K | ﹤0.01% |
21,043
| – | – |
|
1589
PUT
F5
FFIV
$23.5B
| $219K | ﹤0.01% |
1,500
| – | – |
|
1590
Gogo Inc
GOGO
$628M
| $218K | ﹤0.01% |
+15,066
| New | +$235K |
|
1591
ArcelorMittal
MT
$56.3B
| $218K | ﹤0.01% |
7,240
-5,273
| -42% | -$157K |
|
1592
Liberty Energy
LBRT
$3.2B
| $217K | ﹤0.01% |
16,946
-26,017
| -61% | -$385K |
|
1593
Petco
WOOF
$834M
| $217K | ﹤0.01% |
+24,100
| New | +$249K |
|
1594
Sunstone Hotel Investors
SHO
$2.18B
| $217K | ﹤0.01% |
+21,935
| New | +$223K |
|
1595
Scilex Holding
SCLX
$46.7M
| $217K | ﹤0.01% |
+755
| New | +$209K |
|
1596
PUT
Sysco
SYY
$39.8B
| $216K | ﹤0.01% |
2,800
| – | – |
|
|
KZR
1597
DELISTED
Kezar Life Sciences
KZR
| $216K | ﹤0.01% |
+6,907
| New | +$400K |
|
1598
VSE Corp
VSEC
$6.01B
| $215K | ﹤0.01% |
+4,795
| New | +$243K |
|
1599
PUT
Centene
CNC
$31.6B
| $215K | ﹤0.01% |
+3,400
| New | +$241K |
|
1600
United Therapeutics
UTHR
$22B
| $215K | ﹤0.01% |
958
-3,085
| -76% | -$761K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.